Ground state rabbit pluripotent stem cells
Ground state rabbit pluripotent stem cells
批准号:
9345184
负责人:
Qilong Ying
金额:
$22.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-15 至 2019-01-14
关键词:
AdultAgeAnimalsBiological ModelsBiomedical ResearchBody SizeBreedingCRISPR/Cas technologyCell LineCellsChimera organismClustered Regularly Interspaced Short Palindromic RepeatsCommunitiesDerivation procedureDistalEmbryoEmbryologyEnhancersGene TargetingGenerationsGenesGenetic Enhancer ElementGerm CellsGoalsHumanIn VitroInfantInjection of therapeutic agentInner Cell MassLongevityMethodsModelingMusMutationOperative Surgical ProceduresOryctolagus cuniculusPathway interactionsPhasePlayPluripotent Stem CellsPregnancyProcessProductionPropertyRattusRecipeReporterReportingResearchRoleStem cellsSystemTechnologyTestingTherapeuticTimeTranslational ResearchWorkbaseblastocystclinically relevantembryonic stem cellgenetic signaturehuman diseasehuman embryonic stem cellhuman pluripotent stem cellhuman stem cellsimprovedinduced pluripotent stem cellknockin animalnovelnucleaseorgan regenerationsafety testingsmall moleculesmall molecule librariesstem cell biologysuccesstooltransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
To evaluate the therapeutic applications of stem cells, it is essential to develop translational research using
several animal species. Rabbit is a useful model for biomedical research. It has been used to study a number
of human diseases. Compared to mice, rabbits have a more similar embryology and stem cell biology to those
of humans, an adult body size comparable to human infants that allows for practical surgical procedures, and a
longer lifespan to permit a clinically relevant research time. It will be beneficial to establish rabbit pluripotent
stem cell (PSC) lines as a non-murine model system for better understanding human stem cells, and for testing
the safety and efficacy of new stem cell based technologies. The availability of ground state rabbit ESCs in the
age of gene editing is expected to create many novel research tools for translational research community.
Pluripotent rabbit embryonic stem cells (rbESCs) and induced pluripotent stem cells (iPSCs) have been
reported. However, these cells share typical properties of primed stem cells, and all failed to transmit to the
germ cells. The ground state or germline transmitting ESCs and iPSCs are only reported in mice and rats. It
remains to be tested whether ground state ESCs exist in non-rodent species.
The PI of this project made the breakthrough in establishing the first non-murine ground state ESCs in rats.
Here we propose to derive ground state rbESCs. In Aim 1, we will establish an Oct4-ΔPE-GFP reporter cell
line, which would express green florescent in ground state but not in prime state. In Aim 2, we will screen small
molecule library to identify compounds that are beneficial for the ground state in rabbit ESCs. In Aim 3, we will
derive new ground state rabbit ESCs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chicken embryonic stem cells
-
批准号:10719082
-
项目类别:
-
资助金额:$33.1万
-
财政年份:2023
-
负责人:Qilong Ying
-
依托单位:
Rapid egg bioreactor construction for Fabry disease therapeutics
-
批准号:10481061
-
项目类别:
-
资助金额:$25.95万
-
财政年份:2022
-
负责人:Qilong Ying
-
依托单位:
Embryonic stem cell self-renewal
-
批准号:9912157
-
项目类别:
-
资助金额:$33.0万
-
财政年份:2018
-
负责人:Qilong Ying
-
依托单位:
Generation of Cre/lox rats
-
批准号:9924679
-
项目类别:
-
资助金额:$70.36万
-
财政年份:2017
-
负责人:Qilong Ying
-
依托单位:
Generation of Cre/lox rats
-
批准号:9359713
-
项目类别:
-
资助金额:$78.38万
-
财政年份:2017
-
负责人:Qilong Ying
-
依托单位:
DERIVATION, PROPAGATION AND GENETIC MODIFICATION OF RAT EMBRYONIC STEM CELLS
-
批准号:8214587
-
项目类别:
-
资助金额:$40.22万
-
财政年份:2010
-
负责人:Qilong Ying
-
依托单位:
DERIVATION, PROPAGATION AND GENETIC MODIFICATION OF RAT EMBRYONIC STEM CELLS
-
批准号:7791912
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2010
-
负责人:Qilong Ying
-
依托单位:
DERIVATION, PROPAGATION AND GENETIC MODIFICATION OF RAT EMBRYONIC STEM CELLS
-
批准号:8005523
-
项目类别:
-
资助金额:$40.22万
-
财政年份:2010
-
负责人:Qilong Ying
-
依托单位:
DERIVATION, PROPAGATION AND GENETIC MODIFICATION OF RAT EMBRYONIC STEM CELLS
-
批准号:8435437
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2010
-
负责人:Qilong Ying
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: